We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$99.1B
AUM Growth
+$7.92B
Cap. Flow
+$3.27B
Cap. Flow %
3.3%
Top 10 Hldgs %
23.39%
Holding
4,186
New
432
Increased
2,037
Reduced
1,399
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Financials 8.86%
3 Healthcare 8.09%
4 Industrials 6.83%
5 Consumer Discretionary 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFRX
3826
DELISTED
ContraFect Corporation
CFRX
$55K ﹤0.01%
+144
New +$62.1K
PFE icon
3827
CALL
Pfizer
PFE
$152B
$54K ﹤0.01%
111,700
+29,600
+36% +$1.05M
DHI icon
3828
CALL
D.R. Horton
DHI
$42.2B
$53K ﹤0.01%
+15,000
New +$1.17M
TTOO
3829
DELISTED
T2 Biosystems, Inc
TTOO
$52K ﹤0.01%
+6
New +$63.5K
STON
3830
DELISTED
StoneMor Inc.
STON
$52K ﹤0.01%
27,422
+5,432
+25% +$14.2K
KMI icon
3831
CALL
Kinder Morgan
KMI
$70.1B
$51K ﹤0.01%
+52,700
New +$805K
MREO
3832
Mereo BioPharma
MREO
$48.8M
$51K ﹤0.01%
+15,089
New +$53.3K
NAT icon
3833
Nordic American Tanker
NAT
$1.31B
$50K ﹤0.01%
15,338
+1,362
+10% +$4.39K
ACER
3834
DELISTED
Acer Therapeutics Inc
ACER
$50K ﹤0.01%
16,200
BMY icon
3835
CALL
Bristol-Myers Squibb
BMY
$130B
$49K ﹤0.01%
26,500
+3,900
+17% +$243K
MMM icon
3836
CALL
3M
MMM
$94.4B
$49K ﹤0.01%
15,548
-957
-6% -$143K
PLUR icon
3837
Pluri
PLUR
$18.9M
$49K ﹤0.01%
1,282
-751
-37% -$39.4K
SNCR
3838
DELISTED
Synchronoss Technologies
SNCR
$49K ﹤0.01%
1,529
CCO icon
3839
Clear Channel Outdoor Holdings
CCO
$1.23B
$48K ﹤0.01%
26,400
+1,400
+6% +$2.65K
CRON
3840
PUT
Cronos Group
CRON
$1.13B
$48K ﹤0.01%
+26,600
New +$282K
IWF icon
3841
CALL
iShares Russell 1000 Growth ETF
IWF
$127B
$48K ﹤0.01%
40,800
GMLP
3842
DELISTED
Golar LNG Partners LP
GMLP
$48K ﹤0.01%
13,807
-996
-7% -$3.36K
IDEX
3843
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$47K ﹤0.01%
+130
New +$56.6K
BTG icon
3844
CALL
B2Gold
BTG
$6.7B
$45K ﹤0.01%
+190,500
New +$929K
WATT icon
3845
Energous
WATT
$103M
$44K ﹤0.01%
18
+1
+6% +$2.31K
GSAH.WS
3846
DELISTED
GS Acquisition Holdings Corp II Redeemable Warrants, each whole warrant exercisable for one share of
GSAH.WS
$42K ﹤0.01%
+18,917
New +$63K
LCTX icon
3847
Lineage Cell Therapeutics
LCTX
$283M
$40K ﹤0.01%
16,857
-3,021
-15% -$7.25K
PRU icon
3848
CALL
Prudential Financial
PRU
$42.2B
$40K ﹤0.01%
44,200
+100
+0.2% +$8.56K
SJT
3849
San Juan Basin Royalty Trust
SJT
$126M
$40K ﹤0.01%
10,200
-500
-5% -$1.89K
LODE icon
3850
CALL
Comstock
LODE
$270M
$38K ﹤0.01%
+4,190
New +$136K

Similar funds

Raymond James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Raymond James & Associates held 4,186 positions worth $99.1B, up 8.7% from $91.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates deployed $3.27B of net new capital in Q1 2021, opening 432 new positions and adding to 2,037 existing holdings. Its largest new stake was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $671M trimmed.

  • Raymond James & Associates's largest Q1 2021 buy was BlackRock Technology and Private Equity Term Trust: 1,676,875 shares worth $34M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $1.36B increase.
  • Raymond James & Associates's biggest Q1 2021 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $671M.
  • Raymond James & Associates fully exited Sensient Technologies in Q1 2021, selling an estimated $15.6M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $99.1B portfolio in Q1 2021.
  • Raymond James & Associates opened 432 new positions and closed 199 in Q1 2021.
  • Raymond James & Associates's portfolio value rose 8.7% quarter-over-quarter to $99.1B.

Based on Raymond James & Associates's 13F filing for Q1 2021, filed 14 May 2021.